Principia Wealth Advisory’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.08K Buy
99
+42
+74% +$3.67K ﹤0.01% 269
2026
Q1
$4.86K Buy
57
+10
+21% +$891 ﹤0.01% 305
2025
Q4
$3.71K Buy
47
+31
+194% +$2.43K ﹤0.01% 329
2025
Q3
$1.28K Sell
16
-19
-54% -$1.62K ﹤0.01% 556
2025
Q2
$3.18K Buy
35
+18
+106% +$1.64K ﹤0.01% 298
2025
Q1
$1.53K Sell
17
-8
-32% -$716 ﹤0.01% 327
2024
Q4
$2.27K Buy
+25
New +$2.39K ﹤0.01% 229

Other funds holding CL

Principia Wealth Advisory's CL Position: Q2 2026 in Review

Principia Wealth Advisory increased its Colgate-Palmolive (CL) stake by 74% in Q2 2026, buying an estimated $3.67K and bringing the position to 99 shares worth $9.08K. The position accounts for ﹤0.01% of the portfolio, ranked #269.

Principia Wealth Advisory first reported a position in CL in Q4 2024 and has held it in 7 quarters since. 2,013 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Principia Wealth Advisory held 99 shares of Colgate-Palmolive worth $9.08K as of Q2 2026.
  • Principia Wealth Advisory bought 42 Colgate-Palmolive shares in Q2 2026, an estimated $3.67K.
  • Colgate-Palmolive made up ﹤0.01% of Principia Wealth Advisory's portfolio in Q2 2026, its #269 holding.
  • Principia Wealth Advisory first reported a position in Colgate-Palmolive in Q4 2024 and has held it in 7 quarters since.
  • 2,013 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Principia Wealth Advisory's 13F filing for Q2 2026, filed 26 Aug 2026.